FDA review for Bristol-Myers’s liso-cel marketing application to miss the action date

TheWriter November 17, 2020

0 2 Less than a minute

Tags

TheWriter November 17, 2020

0 2 Less than a minute

Read Next

34 mins ago

Show me the money! How you can see returns up to $259M with a DevOps transformation

34 mins ago

New white paper: Strengthening operational resilience in financial services by migrating to Google Cloud

34 mins ago

Here’s Why WiMi Hologram Cloud Stock Soared Again Today

34 mins ago

Raleigh-Durham bankers see falloff in demand, expectations for new PPP

34 mins ago

Durham firm’s $1.59M gig: Archiving Donald Trump’s tweets from his White House days

34 mins ago

Cinebistro is out at Fenton in Cary – so another upscale movie theater is taking its place (Gallery)

34 mins ago

A year in the making: How Cary won multi-state fight for PennyMac’s 320-job expansion

34 mins ago

Why Duke Energy customers could pay $4.8B for plants that don’t produce power

34 mins ago

Belk to file for Chapter 11 bankruptcy, will restructure $450M in debt

34 mins ago

As Orange County expansion goes on, ABB closing Florida plant

Leave a Reply Cancel reply